NPHLA Daily
NPHLA Daily
Monday, October 19, 2026 · 3-minute read
Good morning. Here is what changed across metabolic medicine, pharmacy regulation, aesthetics and healthcare technology since yesterday — every item linked to its source.
Top development today
What changed today in Aesthetics & Longevity: 1 new study
NPHLA tracked 1 new official record on this desk today: 1 new study. First: New research in Aesthetic surgery journal: “Consensus Recommendations on the Diagnosis and Management of Noninflammatory and Inflammatory Nodules Secondary to Poly-L-Lactic Acid Injections”.
Aesthetics & Longevity signal
Consensus Recommendations on the Diagnosis and Management of Noninflammatory and Inflammatory Nodules Secondary to Poly-L-Lactic Acid Injections
From Aesthetic surgery journal.
AI & Technology signal
Artificial intelligence in pharmacy and pharmaceutical sciences: Research output, trends, and thematic priorities - A descriptive analysis of web of science-indexed publications…
From Exploratory research in clinical and social pharmacy.
One thing worth watching
Comments close: Agency Information Collection Activities; Proposed Collection; Comment Request; Registration of Human Drug Compounding Outsourcing Facilities Under the Federal Food, Drug, and…
October 29, 2026 — verified from the Federal Register comments_close_on.
5 things to know
- What changed today in Aesthetics & Longevity: 1 new study
- Artificial intelligence in pharmacy and pharmaceutical sciences: Research output, trends, and thematic priorities - A descriptive analysis of web of science-indexed publications (2010-2025) (Exploratory research in…
- Consensus Recommendations on the Diagnosis and Management of Noninflammatory and Inflammatory Nodules Secondary to Poly-L-Lactic Acid Injections (Aesthetic surgery journal)
Compiled by NPHLA Intelligence from published briefings and official records. Professional information only — not medical or legal advice. Our standards.